Page last updated: 2024-11-04

vorinostat and Carcinoma, Ductal, Breast

vorinostat has been researched along with Carcinoma, Ductal, Breast in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"Short-term vorinostat administration is associated with a significant decrease in expression of proliferation-associated genes in untreated breast cancers."9.17Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer. ( Briest, S; Chao, C; Cheng, Z; Davidson, NE; Espinoza-Delgado, I; Fackler, M; Gabrielson, E; Higgins, M; Jacobs, LK; Jeter, SC; Lange, J; Powers, P; Rudek, MA; Slater, SA; Stearns, V; Sugar, E; Sukumar, S; Tsangaris, TN; Yoshizawa, C, 2013)
"Short-term vorinostat administration is associated with a significant decrease in expression of proliferation-associated genes in untreated breast cancers."5.17Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer. ( Briest, S; Chao, C; Cheng, Z; Davidson, NE; Espinoza-Delgado, I; Fackler, M; Gabrielson, E; Higgins, M; Jacobs, LK; Jeter, SC; Lange, J; Powers, P; Rudek, MA; Slater, SA; Stearns, V; Sugar, E; Sukumar, S; Tsangaris, TN; Yoshizawa, C, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stearns, V1
Jacobs, LK1
Fackler, M1
Tsangaris, TN1
Rudek, MA1
Higgins, M1
Lange, J1
Cheng, Z1
Slater, SA1
Jeter, SC1
Powers, P1
Briest, S1
Chao, C1
Yoshizawa, C1
Sugar, E1
Espinoza-Delgado, I1
Sukumar, S1
Gabrielson, E1
Davidson, NE1

Trials

1 trial available for vorinostat and Carcinoma, Ductal, Breast

ArticleYear
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Jul-15, Volume: 19, Issue:14

    Topics: Adult; Aged; Antineoplastic Agents; Aurora Kinase A; Breast Neoplasms; Carcinoma, Ductal, Breast; Ce

2013